A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic phenotype has not been firmly established. We performed global metabolomics, lip...
প্রধান লেখক: | Fredrik Hoel, August Hoel, Ina K.N. Pettersen, Ingrid G. Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L. Thürmer, Merete E. Gotaas, Christoph Schäfer, Rolf K. Berge, Kristian Sommerfelt, Hans-Peter Marti, Olav Dahl, Olav Mella, Øystein Fluge, Karl J. Tronstad |
---|---|
বিন্যাস: | প্রবন্ধ |
ভাষা: | English |
প্রকাশিত: |
American Society for Clinical investigation
2021-08-01
|
মালা: | JCI Insight |
বিষয়গুলি: | |
অনলাইন ব্যবহার করুন: | https://doi.org/10.1172/jci.insight.149217 |
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
অনুযায়ী: Ingrid G Rekeland, অন্যান্য
প্রকাশিত: (2022-01-01) -
Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
অনুযায়ী: Ingrid G. Rekeland, অন্যান্য
প্রকাশিত: (2022-01-01) -
Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
অনুযায়ী: Ingrid G Rekeland, অন্যান্য
প্রকাশিত: (2024-01-01) -
Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study
অনুযায়ী: Kari Sørland, অন্যান্য
প্রকাশিত: (2021-03-01) -
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
অনুযায়ী: Øystein Fluge, অন্যান্য
প্রকাশিত: (2015-01-01)